nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—CALM1—type 2 diabetes mellitus	0.203	0.54	CbGaD
Pimozide—CYP2E1—type 2 diabetes mellitus	0.0671	0.178	CbGaD
Pimozide—CYP1A2—type 2 diabetes mellitus	0.0639	0.17	CbGaD
Pimozide—CYP3A4—type 2 diabetes mellitus	0.0423	0.112	CbGaD
Pimozide—HTR6—Bromocriptine—type 2 diabetes mellitus	0.0322	0.0863	CbGbCtD
Pimozide—DRD3—Bromocriptine—type 2 diabetes mellitus	0.0265	0.0711	CbGbCtD
Pimozide—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0176	0.0473	CbGbCtD
Pimozide—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0169	0.0452	CbGbCtD
Pimozide—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0155	0.0417	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0135	0.0361	CbGbCtD
Pimozide—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0135	0.0361	CbGbCtD
Pimozide—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0135	0.036	CbGbCtD
Pimozide—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0126	0.0339	CbGbCtD
Pimozide—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.012	0.0321	CbGbCtD
Pimozide—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0107	0.0288	CbGbCtD
Pimozide—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0107	0.0288	CbGbCtD
Pimozide—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0101	0.027	CbGbCtD
Pimozide—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00992	0.0266	CbGbCtD
Pimozide—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00958	0.0257	CbGbCtD
Pimozide—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00915	0.0245	CbGbCtD
Pimozide—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00867	0.0232	CbGbCtD
Pimozide—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00817	0.0219	CbGbCtD
Pimozide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00806	0.0216	CbGbCtD
Pimozide—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00754	0.0202	CbGbCtD
Pimozide—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0072	0.0193	CbGbCtD
Pimozide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00718	0.0192	CbGbCtD
Pimozide—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00681	0.0183	CbGbCtD
Pimozide—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00657	0.0176	CbGbCtD
Pimozide—CYP3A5—Losartan—type 2 diabetes mellitus	0.00624	0.0167	CbGbCtD
Pimozide—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00619	0.0166	CbGbCtD
Pimozide—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00596	0.016	CbGbCtD
Pimozide—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00593	0.0159	CbGbCtD
Pimozide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00574	0.0154	CbGbCtD
Pimozide—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0055	0.0147	CbGbCtD
Pimozide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00519	0.0139	CbGbCtD
Pimozide—CYP2C19—Losartan—type 2 diabetes mellitus	0.00503	0.0135	CbGbCtD
Pimozide—CYP1A2—Losartan—type 2 diabetes mellitus	0.00464	0.0124	CbGbCtD
Pimozide—ABCB1—Glyburide—type 2 diabetes mellitus	0.00444	0.0119	CbGbCtD
Pimozide—ABCB1—Losartan—type 2 diabetes mellitus	0.00406	0.0109	CbGbCtD
Pimozide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00394	0.0105	CbGbCtD
Pimozide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00377	0.0101	CbGbCtD
Pimozide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00377	0.0101	CbGbCtD
Pimozide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00357	0.00956	CbGbCtD
Pimozide—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00266	0.00712	CbGbCtD
Pimozide—CYP3A4—Losartan—type 2 diabetes mellitus	0.00243	0.00652	CbGbCtD
Pimozide—CALM1—sympathetic nervous system—type 2 diabetes mellitus	0.00212	0.0605	CbGeAlD
Pimozide—HTR2A—arteriole—type 2 diabetes mellitus	0.00203	0.0578	CbGeAlD
Pimozide—CALM1—autonomic nervous system—type 2 diabetes mellitus	0.00143	0.0407	CbGeAlD
Pimozide—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00129	0.0369	CbGeAlD
Pimozide—OPRM1—nerve—type 2 diabetes mellitus	0.00111	0.0317	CbGeAlD
Pimozide—CALM2—peripheral nervous system—type 2 diabetes mellitus	0.00104	0.0295	CbGeAlD
Pimozide—CALM1—peripheral nervous system—type 2 diabetes mellitus	0.00103	0.0293	CbGeAlD
Pimozide—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.00087	0.0248	CbGeAlD
Pimozide—CALM2—artery—type 2 diabetes mellitus	0.000814	0.0232	CbGeAlD
Pimozide—CALM1—artery—type 2 diabetes mellitus	0.00081	0.0231	CbGeAlD
Pimozide—CALM2—nerve—type 2 diabetes mellitus	0.000807	0.023	CbGeAlD
Pimozide—HTR2A—hindlimb—type 2 diabetes mellitus	0.000805	0.0229	CbGeAlD
Pimozide—CALM1—nerve—type 2 diabetes mellitus	0.000803	0.0229	CbGeAlD
Pimozide—DRD2—nerve—type 2 diabetes mellitus	0.000742	0.0211	CbGeAlD
Pimozide—CALM2—endothelium—type 2 diabetes mellitus	0.000687	0.0196	CbGeAlD
Pimozide—CALM1—endothelium—type 2 diabetes mellitus	0.000684	0.0195	CbGeAlD
Pimozide—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000628	0.0179	CbGeAlD
Pimozide—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000569	0.0162	CbGeAlD
Pimozide—CALM3—islet of Langerhans—type 2 diabetes mellitus	0.000498	0.0142	CbGeAlD
Pimozide—HTR2A—artery—type 2 diabetes mellitus	0.000493	0.014	CbGeAlD
Pimozide—HTR2A—nerve—type 2 diabetes mellitus	0.000489	0.0139	CbGeAlD
Pimozide—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000487	0.0139	CbGeAlD
Pimozide—Flunarizine—CALM1—type 2 diabetes mellitus	0.000448	0.179	CrCbGaD
Pimozide—CALM3—retina—type 2 diabetes mellitus	0.000426	0.0121	CbGeAlD
Pimozide—HTR2A—endothelium—type 2 diabetes mellitus	0.000417	0.0119	CbGeAlD
Pimozide—CALM3—nephron tubule—type 2 diabetes mellitus	0.000401	0.0114	CbGeAlD
Pimozide—CALM2—islet of Langerhans—type 2 diabetes mellitus	0.000391	0.0111	CbGeAlD
Pimozide—CALM1—islet of Langerhans—type 2 diabetes mellitus	0.000389	0.0111	CbGeAlD
Pimozide—CYP3A7—liver—type 2 diabetes mellitus	0.000372	0.0106	CbGeAlD
Pimozide—Ezetimibe—ABCC2—type 2 diabetes mellitus	0.000358	0.143	CrCbGaD
Pimozide—CHRM2—cardiovascular system—type 2 diabetes mellitus	0.000355	0.0101	CbGeAlD
Pimozide—KCNH2—islet of Langerhans—type 2 diabetes mellitus	0.000354	0.0101	CbGeAlD
Pimozide—CALM3—pancreas—type 2 diabetes mellitus	0.00035	0.00996	CbGeAlD
Pimozide—CALM3—cortex of kidney—type 2 diabetes mellitus	0.000343	0.00977	CbGeAlD
Pimozide—CALM2—retina—type 2 diabetes mellitus	0.000334	0.00952	CbGeAlD
Pimozide—CALM1—retina—type 2 diabetes mellitus	0.000333	0.00947	CbGeAlD
Pimozide—CALM3—adipose tissue—type 2 diabetes mellitus	0.000317	0.00904	CbGeAlD
Pimozide—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000316	0.009	CbGeAlD
Pimozide—CALM2—nephron tubule—type 2 diabetes mellitus	0.000315	0.00896	CbGeAlD
Pimozide—CALM1—nephron tubule—type 2 diabetes mellitus	0.000313	0.00892	CbGeAlD
Pimozide—DRD2—retina—type 2 diabetes mellitus	0.000307	0.00875	CbGeAlD
Pimozide—Sertindole—ADRA2A—type 2 diabetes mellitus	0.000307	0.123	CrCbGaD
Pimozide—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000292	0.00833	CbGeAlD
Pimozide—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000288	0.00819	CbGeAlD
Pimozide—CALM2—cardiovascular system—type 2 diabetes mellitus	0.000283	0.00805	CbGeAlD
Pimozide—Sertindole—HTR2C—type 2 diabetes mellitus	0.000283	0.113	CrCbGaD
Pimozide—CALM1—cardiovascular system—type 2 diabetes mellitus	0.000281	0.00801	CbGeAlD
Pimozide—CALM2—kidney—type 2 diabetes mellitus	0.000277	0.00788	CbGeAlD
Pimozide—CALM1—kidney—type 2 diabetes mellitus	0.000275	0.00784	CbGeAlD
Pimozide—CALM2—pancreas—type 2 diabetes mellitus	0.000275	0.00782	CbGeAlD
Pimozide—CALM1—pancreas—type 2 diabetes mellitus	0.000274	0.00779	CbGeAlD
Pimozide—CALM2—cortex of kidney—type 2 diabetes mellitus	0.000269	0.00767	CbGeAlD
Pimozide—CALM1—cortex of kidney—type 2 diabetes mellitus	0.000268	0.00764	CbGeAlD
Pimozide—KCNH2—cardiovascular system—type 2 diabetes mellitus	0.000256	0.00729	CbGeAlD
Pimozide—Fluspirilene—ADRA2A—type 2 diabetes mellitus	0.00025	0.0999	CrCbGaD
Pimozide—CALM2—adipose tissue—type 2 diabetes mellitus	0.000249	0.0071	CbGeAlD
Pimozide—CALM1—adipose tissue—type 2 diabetes mellitus	0.000248	0.00707	CbGeAlD
Pimozide—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000235	0.0067	CbGeAlD
Pimozide—CALM3—liver—type 2 diabetes mellitus	0.000223	0.00634	CbGeAlD
Pimozide—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.00022	0.00625	CbGeAlD
Pimozide—CYP3A5—kidney—type 2 diabetes mellitus	0.000207	0.00589	CbGeAlD
Pimozide—CYP3A5—pancreas—type 2 diabetes mellitus	0.000206	0.00585	CbGeAlD
Pimozide—HTR2A—retina—type 2 diabetes mellitus	0.000203	0.00577	CbGeAlD
Pimozide—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000202	0.00574	CbGeAlD
Pimozide—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.000197	0.00562	CbGeAlD
Pimozide—CYP2E1—kidney—type 2 diabetes mellitus	0.000193	0.0055	CbGeAlD
Pimozide—CYP2E1—cortex of kidney—type 2 diabetes mellitus	0.000188	0.00535	CbGeAlD
Pimozide—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000187	0.00531	CbGeAlD
Pimozide—HRH1—adipose tissue—type 2 diabetes mellitus	0.000181	0.00515	CbGeAlD
Pimozide—CALM2—liver—type 2 diabetes mellitus	0.000175	0.00498	CbGeAlD
Pimozide—CALM1—liver—type 2 diabetes mellitus	0.000174	0.00496	CbGeAlD
Pimozide—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000171	0.00488	CbGeAlD
Pimozide—HTR2A—kidney—type 2 diabetes mellitus	0.000168	0.00478	CbGeAlD
Pimozide—CYP2C19—liver—type 2 diabetes mellitus	0.000166	0.00473	CbGeAlD
Pimozide—Ezetimibe—CYP3A4—type 2 diabetes mellitus	0.000158	0.0633	CrCbGaD
Pimozide—Astemizole—CYP3A4—type 2 diabetes mellitus	0.000158	0.0633	CrCbGaD
Pimozide—Domperidone—CYP1A2—type 2 diabetes mellitus	0.000156	0.0621	CrCbGaD
Pimozide—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000155	0.00442	CbGeAlD
Pimozide—CYP3A4—kidney—type 2 diabetes mellitus	0.000155	0.00442	CbGeAlD
Pimozide—CYP2D6—kidney—type 2 diabetes mellitus	0.000153	0.00435	CbGeAlD
Pimozide—Sertindole—CYP3A4—type 2 diabetes mellitus	0.000141	0.0564	CrCbGaD
Pimozide—Flunarizine—CYP1A2—type 2 diabetes mellitus	0.000141	0.0563	CrCbGaD
Pimozide—CYP1A2—liver—type 2 diabetes mellitus	0.000136	0.00386	CbGeAlD
Pimozide—ABCB1—retina—type 2 diabetes mellitus	0.000133	0.00378	CbGeAlD
Pimozide—CYP3A5—liver—type 2 diabetes mellitus	0.000131	0.00372	CbGeAlD
Pimozide—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000125	0.00356	CbGeAlD
Pimozide—CYP2E1—liver—type 2 diabetes mellitus	0.000122	0.00347	CbGeAlD
Pimozide—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000112	0.000955	CcSEcCtD
Pimozide—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000112	0.0032	CbGeAlD
Pimozide—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000112	0.000951	CcSEcCtD
Pimozide—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000112	0.000948	CcSEcCtD
Pimozide—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000111	0.000948	CcSEcCtD
Pimozide—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000111	0.000947	CcSEcCtD
Pimozide—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000111	0.000946	CcSEcCtD
Pimozide—Vision blurred—Metformin—type 2 diabetes mellitus	0.000111	0.000946	CcSEcCtD
Pimozide—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000111	0.000945	CcSEcCtD
Pimozide—Convulsion—Orlistat—type 2 diabetes mellitus	0.000111	0.000943	CcSEcCtD
Pimozide—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000111	0.000941	CcSEcCtD
Pimozide—Tremor—Metformin—type 2 diabetes mellitus	0.000111	0.00094	CcSEcCtD
Pimozide—Chest pain—Valsartan—type 2 diabetes mellitus	0.00011	0.000938	CcSEcCtD
Pimozide—Myalgia—Valsartan—type 2 diabetes mellitus	0.00011	0.000938	CcSEcCtD
Pimozide—Sweating—Ramipril—type 2 diabetes mellitus	0.00011	0.000938	CcSEcCtD
Pimozide—Dizziness—Glipizide—type 2 diabetes mellitus	0.00011	0.000937	CcSEcCtD
Pimozide—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00011	0.000935	CcSEcCtD
Pimozide—ABCB1—kidney—type 2 diabetes mellitus	0.00011	0.00313	CbGeAlD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.00011	0.000932	CcSEcCtD
Pimozide—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000109	0.000928	CcSEcCtD
Pimozide—ABCB1—pancreas—type 2 diabetes mellitus	0.000109	0.00311	CbGeAlD
Pimozide—Chest pain—Orlistat—type 2 diabetes mellitus	0.000109	0.000927	CcSEcCtD
Pimozide—Myalgia—Orlistat—type 2 diabetes mellitus	0.000109	0.000927	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000108	0.000921	CcSEcCtD
Pimozide—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000108	0.000918	CcSEcCtD
Pimozide—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000108	0.000915	CcSEcCtD
Pimozide—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000107	0.000913	CcSEcCtD
Pimozide—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000107	0.00091	CcSEcCtD
Pimozide—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000107	0.00305	CbGeAlD
Pimozide—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000107	0.000907	CcSEcCtD
Pimozide—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000106	0.000904	CcSEcCtD
Pimozide—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000106	0.000902	CcSEcCtD
Pimozide—HTR2A—liver—type 2 diabetes mellitus	0.000106	0.00302	CbGeAlD
Pimozide—Vomiting—Glipizide—type 2 diabetes mellitus	0.000106	0.000901	CcSEcCtD
Pimozide—Syncope—Metformin—type 2 diabetes mellitus	0.000106	0.0009	CcSEcCtD
Pimozide—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000106	0.000897	CcSEcCtD
Pimozide—Rash—Glipizide—type 2 diabetes mellitus	0.000105	0.000893	CcSEcCtD
Pimozide—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000105	0.000893	CcSEcCtD
Pimozide—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000105	0.000892	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000105	0.000892	CcSEcCtD
Pimozide—Headache—Glipizide—type 2 diabetes mellitus	0.000104	0.000887	CcSEcCtD
Pimozide—Tremor—Irbesartan—type 2 diabetes mellitus	0.000104	0.000887	CcSEcCtD
Pimozide—Palpitations—Metformin—type 2 diabetes mellitus	0.000104	0.000887	CcSEcCtD
Pimozide—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000104	0.000885	CcSEcCtD
Pimozide—Shock—Valsartan—type 2 diabetes mellitus	0.000104	0.000885	CcSEcCtD
Pimozide—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000104	0.000882	CcSEcCtD
Pimozide—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000104	0.000882	CcSEcCtD
Pimozide—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000103	0.000875	CcSEcCtD
Pimozide—Domperidone—CYP3A4—type 2 diabetes mellitus	0.000103	0.0411	CrCbGaD
Pimozide—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000103	0.000874	CcSEcCtD
Pimozide—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000103	0.000874	CcSEcCtD
Pimozide—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000103	0.000872	CcSEcCtD
Pimozide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000103	0.000871	CcSEcCtD
Pimozide—Agitation—Irbesartan—type 2 diabetes mellitus	0.000102	0.00087	CcSEcCtD
Pimozide—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000102	0.00087	CcSEcCtD
Pimozide—Hypertension—Metformin—type 2 diabetes mellitus	0.000102	0.000866	CcSEcCtD
Pimozide—Urticaria—Glyburide—type 2 diabetes mellitus	0.000102	0.000866	CcSEcCtD
Pimozide—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000102	0.000863	CcSEcCtD
Pimozide—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000101	0.000863	CcSEcCtD
Pimozide—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000101	0.000859	CcSEcCtD
Pimozide—Anorexia—Valsartan—type 2 diabetes mellitus	0.000101	0.000857	CcSEcCtD
Pimozide—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000101	0.000857	CcSEcCtD
Pimozide—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000101	0.000856	CcSEcCtD
Pimozide—Myalgia—Metformin—type 2 diabetes mellitus	0.000101	0.000854	CcSEcCtD
Pimozide—Chest pain—Metformin—type 2 diabetes mellitus	0.000101	0.000854	CcSEcCtD
Pimozide—Headache—Pioglitazone—type 2 diabetes mellitus	0.0001	0.00085	CcSEcCtD
Pimozide—Syncope—Irbesartan—type 2 diabetes mellitus	9.99e-05	0.000849	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	9.98e-05	0.000848	CcSEcCtD
Pimozide—Leukopenia—Irbesartan—type 2 diabetes mellitus	9.97e-05	0.000848	CcSEcCtD
Pimozide—Visual impairment—Ramipril—type 2 diabetes mellitus	9.95e-05	0.000846	CcSEcCtD
Pimozide—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	9.94e-05	0.000845	CcSEcCtD
Pimozide—ABCB1—adipose tissue—type 2 diabetes mellitus	9.91e-05	0.00282	CbGeAlD
Pimozide—Nausea—Glipizide—type 2 diabetes mellitus	9.9e-05	0.000841	CcSEcCtD
Pimozide—Vomiting—Glimepiride—type 2 diabetes mellitus	9.89e-05	0.00084	CcSEcCtD
Pimozide—Hypotension—Valsartan—type 2 diabetes mellitus	9.89e-05	0.00084	CcSEcCtD
Pimozide—Vision blurred—Losartan—type 2 diabetes mellitus	9.88e-05	0.00084	CcSEcCtD
Pimozide—Vomiting—Sitagliptin—type 2 diabetes mellitus	9.86e-05	0.000838	CcSEcCtD
Pimozide—Constipation—Gliclazide—type 2 diabetes mellitus	9.85e-05	0.000837	CcSEcCtD
Pimozide—Tremor—Losartan—type 2 diabetes mellitus	9.82e-05	0.000835	CcSEcCtD
Pimozide—CYP3A4—liver—type 2 diabetes mellitus	9.82e-05	0.00279	CbGeAlD
Pimozide—Rash—Glimepiride—type 2 diabetes mellitus	9.81e-05	0.000833	CcSEcCtD
Pimozide—Dermatitis—Glimepiride—type 2 diabetes mellitus	9.8e-05	0.000833	CcSEcCtD
Pimozide—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	9.79e-05	0.000832	CcSEcCtD
Pimozide—Rash—Sitagliptin—type 2 diabetes mellitus	9.78e-05	0.000831	CcSEcCtD
Pimozide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	9.77e-05	0.00083	CcSEcCtD
Pimozide—Headache—Glimepiride—type 2 diabetes mellitus	9.74e-05	0.000828	CcSEcCtD
Pimozide—Headache—Sitagliptin—type 2 diabetes mellitus	9.71e-05	0.000825	CcSEcCtD
Pimozide—Anaemia—Losartan—type 2 diabetes mellitus	9.69e-05	0.000824	CcSEcCtD
Pimozide—CYP2D6—liver—type 2 diabetes mellitus	9.66e-05	0.00275	CbGeAlD
Pimozide—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	9.64e-05	0.000819	CcSEcCtD
Pimozide—Agitation—Losartan—type 2 diabetes mellitus	9.64e-05	0.000819	CcSEcCtD
Pimozide—Hypertension—Irbesartan—type 2 diabetes mellitus	9.62e-05	0.000818	CcSEcCtD
Pimozide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	9.6e-05	0.000816	CcSEcCtD
Pimozide—Insomnia—Valsartan—type 2 diabetes mellitus	9.57e-05	0.000813	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	9.53e-05	0.00081	CcSEcCtD
Pimozide—Chest pain—Irbesartan—type 2 diabetes mellitus	9.49e-05	0.000806	CcSEcCtD
Pimozide—Myalgia—Irbesartan—type 2 diabetes mellitus	9.49e-05	0.000806	CcSEcCtD
Pimozide—Shock—Metformin—type 2 diabetes mellitus	9.48e-05	0.000806	CcSEcCtD
Pimozide—Insomnia—Orlistat—type 2 diabetes mellitus	9.46e-05	0.000804	CcSEcCtD
Pimozide—Nervous system disorder—Metformin—type 2 diabetes mellitus	9.45e-05	0.000803	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	9.42e-05	0.000801	CcSEcCtD
Pimozide—Somnolence—Valsartan—type 2 diabetes mellitus	9.41e-05	0.0008	CcSEcCtD
Pimozide—Syncope—Losartan—type 2 diabetes mellitus	9.4e-05	0.000799	CcSEcCtD
Pimozide—Leukopenia—Losartan—type 2 diabetes mellitus	9.39e-05	0.000798	CcSEcCtD
Pimozide—Skin disorder—Metformin—type 2 diabetes mellitus	9.36e-05	0.000796	CcSEcCtD
Pimozide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	9.32e-05	0.000792	CcSEcCtD
Pimozide—Dizziness—Bromocriptine—type 2 diabetes mellitus	9.28e-05	0.000789	CcSEcCtD
Pimozide—Dry mouth—Irbesartan—type 2 diabetes mellitus	9.28e-05	0.000789	CcSEcCtD
Pimozide—Palpitations—Losartan—type 2 diabetes mellitus	9.27e-05	0.000788	CcSEcCtD
Pimozide—Nausea—Glimepiride—type 2 diabetes mellitus	9.24e-05	0.000785	CcSEcCtD
Pimozide—Loss of consciousness—Losartan—type 2 diabetes mellitus	9.22e-05	0.000783	CcSEcCtD
Pimozide—Nausea—Sitagliptin—type 2 diabetes mellitus	9.21e-05	0.000783	CcSEcCtD
Pimozide—Asthenia—Glyburide—type 2 diabetes mellitus	9.2e-05	0.000782	CcSEcCtD
Pimozide—Decreased appetite—Valsartan—type 2 diabetes mellitus	9.2e-05	0.000782	CcSEcCtD
Pimozide—Anorexia—Metformin—type 2 diabetes mellitus	9.19e-05	0.000781	CcSEcCtD
Pimozide—Urticaria—Gliclazide—type 2 diabetes mellitus	9.15e-05	0.000778	CcSEcCtD
Pimozide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	9.14e-05	0.000776	CcSEcCtD
Pimozide—Decreased appetite—Orlistat—type 2 diabetes mellitus	9.09e-05	0.000773	CcSEcCtD
Pimozide—Pruritus—Glyburide—type 2 diabetes mellitus	9.07e-05	0.000771	CcSEcCtD
Pimozide—Mental disorder—Ramipril—type 2 diabetes mellitus	9.05e-05	0.000769	CcSEcCtD
Pimozide—Constipation—Valsartan—type 2 diabetes mellitus	9.05e-05	0.000769	CcSEcCtD
Pimozide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	9.03e-05	0.000767	CcSEcCtD
Pimozide—Hypotension—Metformin—type 2 diabetes mellitus	9e-05	0.000765	CcSEcCtD
Pimozide—Shock—Irbesartan—type 2 diabetes mellitus	8.95e-05	0.00076	CcSEcCtD
Pimozide—Chest pain—Losartan—type 2 diabetes mellitus	8.93e-05	0.000759	CcSEcCtD
Pimozide—Myalgia—Losartan—type 2 diabetes mellitus	8.93e-05	0.000759	CcSEcCtD
Pimozide—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.92e-05	0.000758	CcSEcCtD
Pimozide—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	8.92e-05	0.000758	CcSEcCtD
Pimozide—Tachycardia—Irbesartan—type 2 diabetes mellitus	8.88e-05	0.000754	CcSEcCtD
Pimozide—Rash—Bromocriptine—type 2 diabetes mellitus	8.85e-05	0.000752	CcSEcCtD
Pimozide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.84e-05	0.000751	CcSEcCtD
Pimozide—Skin disorder—Irbesartan—type 2 diabetes mellitus	8.83e-05	0.000751	CcSEcCtD
Pimozide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	8.79e-05	0.000747	CcSEcCtD
Pimozide—Headache—Bromocriptine—type 2 diabetes mellitus	8.79e-05	0.000747	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	8.78e-05	0.000746	CcSEcCtD
Pimozide—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.78e-05	0.000746	CcSEcCtD
Pimozide—Dry mouth—Losartan—type 2 diabetes mellitus	8.73e-05	0.000742	CcSEcCtD
Pimozide—Anorexia—Irbesartan—type 2 diabetes mellitus	8.67e-05	0.000737	CcSEcCtD
Pimozide—Muscle spasms—Ramipril—type 2 diabetes mellitus	8.64e-05	0.000735	CcSEcCtD
Pimozide—Somnolence—Metformin—type 2 diabetes mellitus	8.57e-05	0.000728	CcSEcCtD
Pimozide—Hypotension—Irbesartan—type 2 diabetes mellitus	8.5e-05	0.000722	CcSEcCtD
Pimozide—Tremor—Ramipril—type 2 diabetes mellitus	8.42e-05	0.000716	CcSEcCtD
Pimozide—Shock—Losartan—type 2 diabetes mellitus	8.42e-05	0.000716	CcSEcCtD
Pimozide—Urticaria—Valsartan—type 2 diabetes mellitus	8.41e-05	0.000714	CcSEcCtD
Pimozide—Nervous system disorder—Losartan—type 2 diabetes mellitus	8.39e-05	0.000713	CcSEcCtD
Pimozide—Decreased appetite—Metformin—type 2 diabetes mellitus	8.38e-05	0.000712	CcSEcCtD
Pimozide—Tachycardia—Losartan—type 2 diabetes mellitus	8.35e-05	0.00071	CcSEcCtD
Pimozide—Nausea—Bromocriptine—type 2 diabetes mellitus	8.33e-05	0.000708	CcSEcCtD
Pimozide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	8.32e-05	0.000707	CcSEcCtD
Pimozide—Urticaria—Orlistat—type 2 diabetes mellitus	8.31e-05	0.000706	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	8.28e-05	0.000704	CcSEcCtD
Pimozide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	8.27e-05	0.000703	CcSEcCtD
Pimozide—Asthenia—Gliclazide—type 2 diabetes mellitus	8.26e-05	0.000702	CcSEcCtD
Pimozide—Agitation—Ramipril—type 2 diabetes mellitus	8.26e-05	0.000702	CcSEcCtD
Pimozide—Constipation—Metformin—type 2 diabetes mellitus	8.24e-05	0.0007	CcSEcCtD
Pimozide—Anorexia—Losartan—type 2 diabetes mellitus	8.16e-05	0.000693	CcSEcCtD
Pimozide—Vomiting—Glyburide—type 2 diabetes mellitus	8.16e-05	0.000693	CcSEcCtD
Pimozide—Pruritus—Gliclazide—type 2 diabetes mellitus	8.15e-05	0.000693	CcSEcCtD
Pimozide—Rash—Glyburide—type 2 diabetes mellitus	8.09e-05	0.000687	CcSEcCtD
Pimozide—Somnolence—Irbesartan—type 2 diabetes mellitus	8.08e-05	0.000687	CcSEcCtD
Pimozide—Dermatitis—Glyburide—type 2 diabetes mellitus	8.08e-05	0.000687	CcSEcCtD
Pimozide—Syncope—Ramipril—type 2 diabetes mellitus	8.06e-05	0.000685	CcSEcCtD
Pimozide—Leukopenia—Ramipril—type 2 diabetes mellitus	8.05e-05	0.000684	CcSEcCtD
Pimozide—Headache—Glyburide—type 2 diabetes mellitus	8.04e-05	0.000683	CcSEcCtD
Pimozide—Hypotension—Losartan—type 2 diabetes mellitus	8e-05	0.00068	CcSEcCtD
Pimozide—Palpitations—Ramipril—type 2 diabetes mellitus	7.95e-05	0.000675	CcSEcCtD
Pimozide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	7.9e-05	0.000672	CcSEcCtD
Pimozide—Loss of consciousness—Ramipril—type 2 diabetes mellitus	7.9e-05	0.000672	CcSEcCtD
Pimozide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	7.88e-05	0.00067	CcSEcCtD
Pimozide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	7.85e-05	0.000667	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	7.8e-05	0.000663	CcSEcCtD
Pimozide—Convulsion—Ramipril—type 2 diabetes mellitus	7.79e-05	0.000662	CcSEcCtD
Pimozide—Constipation—Irbesartan—type 2 diabetes mellitus	7.78e-05	0.000661	CcSEcCtD
Pimozide—Insomnia—Losartan—type 2 diabetes mellitus	7.74e-05	0.000658	CcSEcCtD
Pimozide—Urticaria—Metformin—type 2 diabetes mellitus	7.65e-05	0.000651	CcSEcCtD
Pimozide—Chest pain—Ramipril—type 2 diabetes mellitus	7.65e-05	0.000651	CcSEcCtD
Pimozide—Myalgia—Ramipril—type 2 diabetes mellitus	7.65e-05	0.000651	CcSEcCtD
Pimozide—Nausea—Glyburide—type 2 diabetes mellitus	7.62e-05	0.000648	CcSEcCtD
Pimozide—Dizziness—Gliclazide—type 2 diabetes mellitus	7.62e-05	0.000647	CcSEcCtD
Pimozide—Somnolence—Losartan—type 2 diabetes mellitus	7.61e-05	0.000647	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	7.6e-05	0.000646	CcSEcCtD
Pimozide—Asthenia—Valsartan—type 2 diabetes mellitus	7.59e-05	0.000645	CcSEcCtD
Pimozide—Asthenia—Orlistat—type 2 diabetes mellitus	7.5e-05	0.000638	CcSEcCtD
Pimozide—Pruritus—Valsartan—type 2 diabetes mellitus	7.49e-05	0.000636	CcSEcCtD
Pimozide—Dry mouth—Ramipril—type 2 diabetes mellitus	7.49e-05	0.000636	CcSEcCtD
Pimozide—Decreased appetite—Losartan—type 2 diabetes mellitus	7.44e-05	0.000632	CcSEcCtD
Pimozide—Pruritus—Orlistat—type 2 diabetes mellitus	7.4e-05	0.000629	CcSEcCtD
Pimozide—Vomiting—Gliclazide—type 2 diabetes mellitus	7.32e-05	0.000622	CcSEcCtD
Pimozide—Constipation—Losartan—type 2 diabetes mellitus	7.32e-05	0.000622	CcSEcCtD
Pimozide—Rash—Gliclazide—type 2 diabetes mellitus	7.26e-05	0.000617	CcSEcCtD
Pimozide—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.26e-05	0.000617	CcSEcCtD
Pimozide—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.24e-05	0.000615	CcSEcCtD
Pimozide—Urticaria—Irbesartan—type 2 diabetes mellitus	7.22e-05	0.000614	CcSEcCtD
Pimozide—Shock—Ramipril—type 2 diabetes mellitus	7.22e-05	0.000614	CcSEcCtD
Pimozide—Headache—Gliclazide—type 2 diabetes mellitus	7.22e-05	0.000613	CcSEcCtD
Pimozide—Nervous system disorder—Ramipril—type 2 diabetes mellitus	7.2e-05	0.000612	CcSEcCtD
Pimozide—Tachycardia—Ramipril—type 2 diabetes mellitus	7.16e-05	0.000609	CcSEcCtD
Pimozide—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.15e-05	0.000608	CcSEcCtD
Pimozide—Skin disorder—Ramipril—type 2 diabetes mellitus	7.13e-05	0.000606	CcSEcCtD
Pimozide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.09e-05	0.000603	CcSEcCtD
Pimozide—Dizziness—Valsartan—type 2 diabetes mellitus	7e-05	0.000595	CcSEcCtD
Pimozide—Anorexia—Ramipril—type 2 diabetes mellitus	6.99e-05	0.000595	CcSEcCtD
Pimozide—ABCB1—liver—type 2 diabetes mellitus	6.95e-05	0.00198	CbGeAlD
Pimozide—Dizziness—Orlistat—type 2 diabetes mellitus	6.91e-05	0.000588	CcSEcCtD
Pimozide—Asthenia—Metformin—type 2 diabetes mellitus	6.91e-05	0.000588	CcSEcCtD
Pimozide—Hypotension—Ramipril—type 2 diabetes mellitus	6.86e-05	0.000583	CcSEcCtD
Pimozide—Nausea—Gliclazide—type 2 diabetes mellitus	6.84e-05	0.000581	CcSEcCtD
Pimozide—Pruritus—Metformin—type 2 diabetes mellitus	6.82e-05	0.000579	CcSEcCtD
Pimozide—Urticaria—Losartan—type 2 diabetes mellitus	6.8e-05	0.000578	CcSEcCtD
Pimozide—Vomiting—Valsartan—type 2 diabetes mellitus	6.73e-05	0.000572	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.69e-05	0.000568	CcSEcCtD
Pimozide—Rash—Valsartan—type 2 diabetes mellitus	6.67e-05	0.000567	CcSEcCtD
Pimozide—Dermatitis—Valsartan—type 2 diabetes mellitus	6.67e-05	0.000567	CcSEcCtD
Pimozide—Vomiting—Orlistat—type 2 diabetes mellitus	6.65e-05	0.000565	CcSEcCtD
Pimozide—Insomnia—Ramipril—type 2 diabetes mellitus	6.64e-05	0.000564	CcSEcCtD
Pimozide—Headache—Valsartan—type 2 diabetes mellitus	6.63e-05	0.000563	CcSEcCtD
Pimozide—Diarrhoea—Metformin—type 2 diabetes mellitus	6.59e-05	0.00056	CcSEcCtD
Pimozide—Rash—Orlistat—type 2 diabetes mellitus	6.59e-05	0.00056	CcSEcCtD
Pimozide—Dermatitis—Orlistat—type 2 diabetes mellitus	6.59e-05	0.00056	CcSEcCtD
Pimozide—Headache—Orlistat—type 2 diabetes mellitus	6.55e-05	0.000557	CcSEcCtD
Pimozide—Asthenia—Irbesartan—type 2 diabetes mellitus	6.52e-05	0.000555	CcSEcCtD
Pimozide—Somnolence—Ramipril—type 2 diabetes mellitus	6.52e-05	0.000554	CcSEcCtD
Pimozide—Pruritus—Irbesartan—type 2 diabetes mellitus	6.43e-05	0.000547	CcSEcCtD
Pimozide—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.38e-05	0.000542	CcSEcCtD
Pimozide—Dizziness—Metformin—type 2 diabetes mellitus	6.37e-05	0.000542	CcSEcCtD
Pimozide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	6.34e-05	0.000538	CcSEcCtD
Pimozide—Nausea—Valsartan—type 2 diabetes mellitus	6.29e-05	0.000534	CcSEcCtD
Pimozide—Constipation—Ramipril—type 2 diabetes mellitus	6.28e-05	0.000533	CcSEcCtD
Pimozide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.22e-05	0.000529	CcSEcCtD
Pimozide—Nausea—Orlistat—type 2 diabetes mellitus	6.21e-05	0.000528	CcSEcCtD
Pimozide—Asthenia—Losartan—type 2 diabetes mellitus	6.14e-05	0.000522	CcSEcCtD
Pimozide—Vomiting—Metformin—type 2 diabetes mellitus	6.13e-05	0.000521	CcSEcCtD
Pimozide—Rash—Metformin—type 2 diabetes mellitus	6.08e-05	0.000516	CcSEcCtD
Pimozide—Dermatitis—Metformin—type 2 diabetes mellitus	6.07e-05	0.000516	CcSEcCtD
Pimozide—Pruritus—Losartan—type 2 diabetes mellitus	6.05e-05	0.000515	CcSEcCtD
Pimozide—Headache—Metformin—type 2 diabetes mellitus	6.04e-05	0.000513	CcSEcCtD
Pimozide—Dizziness—Irbesartan—type 2 diabetes mellitus	6.01e-05	0.000511	CcSEcCtD
Pimozide—Diarrhoea—Losartan—type 2 diabetes mellitus	5.86e-05	0.000498	CcSEcCtD
Pimozide—Urticaria—Ramipril—type 2 diabetes mellitus	5.83e-05	0.000495	CcSEcCtD
Pimozide—Vomiting—Irbesartan—type 2 diabetes mellitus	5.78e-05	0.000491	CcSEcCtD
Pimozide—Rash—Irbesartan—type 2 diabetes mellitus	5.73e-05	0.000487	CcSEcCtD
Pimozide—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.73e-05	0.000487	CcSEcCtD
Pimozide—Nausea—Metformin—type 2 diabetes mellitus	5.72e-05	0.000486	CcSEcCtD
Pimozide—Headache—Irbesartan—type 2 diabetes mellitus	5.7e-05	0.000484	CcSEcCtD
Pimozide—Dizziness—Losartan—type 2 diabetes mellitus	5.66e-05	0.000481	CcSEcCtD
Pimozide—Vomiting—Losartan—type 2 diabetes mellitus	5.44e-05	0.000462	CcSEcCtD
Pimozide—Nausea—Irbesartan—type 2 diabetes mellitus	5.4e-05	0.000459	CcSEcCtD
Pimozide—Rash—Losartan—type 2 diabetes mellitus	5.4e-05	0.000459	CcSEcCtD
Pimozide—Dermatitis—Losartan—type 2 diabetes mellitus	5.39e-05	0.000458	CcSEcCtD
Pimozide—Headache—Losartan—type 2 diabetes mellitus	5.36e-05	0.000456	CcSEcCtD
Pimozide—Asthenia—Ramipril—type 2 diabetes mellitus	5.26e-05	0.000447	CcSEcCtD
Pimozide—Pruritus—Ramipril—type 2 diabetes mellitus	5.19e-05	0.000441	CcSEcCtD
Pimozide—Nausea—Losartan—type 2 diabetes mellitus	5.08e-05	0.000432	CcSEcCtD
Pimozide—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.02e-05	0.000427	CcSEcCtD
Pimozide—Dizziness—Ramipril—type 2 diabetes mellitus	4.85e-05	0.000412	CcSEcCtD
Pimozide—Vomiting—Ramipril—type 2 diabetes mellitus	4.67e-05	0.000397	CcSEcCtD
Pimozide—Rash—Ramipril—type 2 diabetes mellitus	4.63e-05	0.000393	CcSEcCtD
Pimozide—Dermatitis—Ramipril—type 2 diabetes mellitus	4.62e-05	0.000393	CcSEcCtD
Pimozide—Headache—Ramipril—type 2 diabetes mellitus	4.6e-05	0.000391	CcSEcCtD
Pimozide—Nausea—Ramipril—type 2 diabetes mellitus	4.36e-05	0.00037	CcSEcCtD
Pimozide—OPRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.29e-06	1.36e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.29e-06	1.36e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.28e-06	1.35e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.28e-06	1.35e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—NOS3—type 2 diabetes mellitus	1.28e-06	1.35e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—NOS3—type 2 diabetes mellitus	1.28e-06	1.35e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.28e-06	1.34e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.28e-06	1.34e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.28e-06	1.34e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.28e-06	1.34e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.28e-06	1.34e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—SRC—type 2 diabetes mellitus	1.27e-06	1.33e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.27e-06	1.33e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—INS—type 2 diabetes mellitus	1.26e-06	1.33e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.26e-06	1.33e-05	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—AKT1—type 2 diabetes mellitus	1.26e-06	1.32e-05	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—AKT1—type 2 diabetes mellitus	1.26e-06	1.32e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.26e-06	1.32e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.26e-06	1.32e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.26e-06	1.32e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.25e-06	1.32e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.25e-06	1.31e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.25e-06	1.31e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.25e-06	1.31e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.24e-06	1.31e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.24e-06	1.3e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.23e-06	1.3e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.23e-06	1.29e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—SRC—type 2 diabetes mellitus	1.23e-06	1.29e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—SRC—type 2 diabetes mellitus	1.23e-06	1.29e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—INS—type 2 diabetes mellitus	1.22e-06	1.29e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—INS—type 2 diabetes mellitus	1.22e-06	1.29e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.22e-06	1.29e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.22e-06	1.28e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	1.22e-06	1.28e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	1.22e-06	1.28e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.22e-06	1.28e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.21e-06	1.28e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PTGS2—type 2 diabetes mellitus	1.21e-06	1.27e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.2e-06	1.26e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.2e-06	1.26e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.2e-06	1.26e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.2e-06	1.26e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.2e-06	1.26e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.18e-06	1.24e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.18e-06	1.24e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.18e-06	1.24e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.18e-06	1.24e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.18e-06	1.24e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.18e-06	1.24e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.18e-06	1.24e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.17e-06	1.23e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PTGS2—type 2 diabetes mellitus	1.17e-06	1.23e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PTGS2—type 2 diabetes mellitus	1.17e-06	1.23e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.17e-06	1.23e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—SRC—type 2 diabetes mellitus	1.17e-06	1.23e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.17e-06	1.23e-05	CbGpPWpGaD
Pimozide—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.16e-06	1.22e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.16e-06	1.22e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.16e-06	1.22e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.15e-06	1.21e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.15e-06	1.21e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.15e-06	1.21e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.15e-06	1.2e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.14e-06	1.2e-05	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.14e-06	1.2e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.14e-06	1.2e-05	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.14e-06	1.2e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.13e-06	1.19e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—SRC—type 2 diabetes mellitus	1.13e-06	1.19e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—SRC—type 2 diabetes mellitus	1.13e-06	1.19e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.13e-06	1.19e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.13e-06	1.19e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.13e-06	1.18e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.12e-06	1.18e-05	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.12e-06	1.18e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.12e-06	1.18e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.12e-06	1.18e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.11e-06	1.17e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.11e-06	1.17e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—EGFR—type 2 diabetes mellitus	1.11e-06	1.17e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.11e-06	1.17e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.11e-06	1.17e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.11e-06	1.16e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.1e-06	1.16e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.09e-06	1.15e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.09e-06	1.14e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.08e-06	1.14e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.08e-06	1.14e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.08e-06	1.13e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.08e-06	1.13e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.08e-06	1.13e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.08e-06	1.13e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—EGFR—type 2 diabetes mellitus	1.07e-06	1.13e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—EGFR—type 2 diabetes mellitus	1.07e-06	1.13e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.07e-06	1.13e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.07e-06	1.13e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.07e-06	1.13e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.07e-06	1.13e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.07e-06	1.13e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.07e-06	1.13e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.07e-06	1.13e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.07e-06	1.12e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.06e-06	1.12e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.06e-06	1.11e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.06e-06	1.11e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.06e-06	1.11e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.06e-06	1.11e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.06e-06	1.11e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.05e-06	1.11e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.05e-06	1.1e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—TGFB1—type 2 diabetes mellitus	1.05e-06	1.1e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—RELA—type 2 diabetes mellitus	1.04e-06	1.1e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.04e-06	1.09e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—IL6—type 2 diabetes mellitus	1.04e-06	1.09e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.04e-06	1.09e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.04e-06	1.09e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.03e-06	1.09e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.03e-06	1.08e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.03e-06	1.08e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—EGFR—type 2 diabetes mellitus	1.03e-06	1.08e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.02e-06	1.07e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.02e-06	1.07e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—TGFB1—type 2 diabetes mellitus	1.01e-06	1.06e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—TGFB1—type 2 diabetes mellitus	1.01e-06	1.06e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.01e-06	1.06e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.01e-06	1.06e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1e-06	1.06e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1e-06	1.06e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1e-06	1.06e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	1e-06	1.06e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1e-06	1.05e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—EGFR—type 2 diabetes mellitus	9.92e-07	1.04e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—EGFR—type 2 diabetes mellitus	9.92e-07	1.04e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	9.89e-07	1.04e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	9.87e-07	1.04e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	9.85e-07	1.04e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	9.85e-07	1.04e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.77e-07	1.03e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.74e-07	1.02e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	9.7e-07	1.02e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	9.65e-07	1.01e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.62e-07	1.01e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	9.61e-07	1.01e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.6e-07	1.01e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.6e-07	1.01e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	9.46e-07	9.95e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	9.46e-07	9.95e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.44e-07	9.93e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	9.41e-07	9.9e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.41e-07	9.89e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	9.36e-07	9.85e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.35e-07	9.83e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	9.32e-07	9.8e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	9.25e-07	9.72e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	9.19e-07	9.66e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	9.14e-07	9.61e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.1e-07	9.57e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.1e-07	9.57e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.04e-07	9.51e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.04e-07	9.51e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.97e-07	9.43e-06	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	8.92e-07	9.38e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.89e-07	9.35e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	8.87e-07	9.33e-06	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	8.83e-07	9.29e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.83e-07	9.28e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.81e-07	9.26e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.8e-07	9.25e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.8e-07	9.25e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	8.7e-07	9.15e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.67e-07	9.11e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	8.66e-07	9.1e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.66e-07	9.1e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.64e-07	9.08e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.62e-07	9.07e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.6e-07	9.04e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.6e-07	9.04e-06	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL6—type 2 diabetes mellitus	8.54e-07	8.98e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.51e-07	8.95e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.51e-07	8.95e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.5e-07	8.94e-06	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	8.46e-07	8.9e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	8.43e-07	8.86e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	8.38e-07	8.81e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.34e-07	8.77e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.34e-07	8.77e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	8.29e-07	8.72e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL6—type 2 diabetes mellitus	8.26e-07	8.69e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL6—type 2 diabetes mellitus	8.26e-07	8.69e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	8.26e-07	8.69e-06	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.23e-07	8.65e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—SRC—type 2 diabetes mellitus	8.2e-07	8.62e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	8.17e-07	8.59e-06	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.15e-07	8.57e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	8.02e-07	8.43e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	8.02e-07	8.43e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.98e-07	8.4e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—SRC—type 2 diabetes mellitus	7.93e-07	8.34e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—SRC—type 2 diabetes mellitus	7.93e-07	8.34e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—IL6—type 2 diabetes mellitus	7.89e-07	8.29e-06	CbGpPWpGaD
Pimozide—CALM3—Immune System—AKT1—type 2 diabetes mellitus	7.88e-07	8.28e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.72e-07	8.12e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.72e-07	8.12e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.7e-07	8.1e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—IL6—type 2 diabetes mellitus	7.63e-07	8.02e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—IL6—type 2 diabetes mellitus	7.63e-07	8.02e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—AKT1—type 2 diabetes mellitus	7.62e-07	8.01e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—AKT1—type 2 diabetes mellitus	7.62e-07	8.01e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	7.33e-07	7.71e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.33e-07	7.71e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—AKT1—type 2 diabetes mellitus	7.27e-07	7.65e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	7.19e-07	7.57e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.18e-07	7.56e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.1e-07	7.47e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.09e-07	7.45e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.09e-07	7.45e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	7.06e-07	7.42e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—AKT1—type 2 diabetes mellitus	7.04e-07	7.4e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—AKT1—type 2 diabetes mellitus	7.04e-07	7.4e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.95e-07	7.31e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.95e-07	7.31e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	6.76e-07	7.11e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.65e-07	6.99e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	6.64e-07	6.98e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	6.53e-07	6.87e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	6.47e-07	6.8e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.24e-07	6.56e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	6.19e-07	6.51e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	6.19e-07	6.51e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.14e-07	6.45e-06	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	6.13e-07	6.45e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.12e-07	6.44e-06	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	6.12e-07	6.43e-06	CbGpPWpGaD
Pimozide—CALM3—Metabolism—AKT1—type 2 diabetes mellitus	6.09e-07	6.41e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.03e-07	6.34e-06	CbGpPWpGaD
Pimozide—CALM2—Metabolism—AKT1—type 2 diabetes mellitus	5.89e-07	6.2e-06	CbGpPWpGaD
Pimozide—CALM1—Metabolism—AKT1—type 2 diabetes mellitus	5.89e-07	6.2e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	5.66e-07	5.95e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL6—type 2 diabetes mellitus	5.52e-07	5.81e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.34e-07	5.62e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL6—type 2 diabetes mellitus	5.34e-07	5.62e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.09e-07	5.36e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.93e-07	5.18e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.93e-07	5.18e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	4.73e-07	4.97e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	4.62e-07	4.85e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	4.35e-07	4.57e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	3.69e-07	3.88e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.84e-07	2.99e-06	CbGpPWpGaD
